Reno Debets

9.3k total citations · 1 hit paper
161 papers, 6.2k citations indexed

About

Reno Debets is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Reno Debets has authored 161 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Oncology, 96 papers in Immunology and 37 papers in Molecular Biology. Recurrent topics in Reno Debets's work include CAR-T cell therapy research (80 papers), Immunotherapy and Immune Responses (53 papers) and Cancer Immunotherapy and Biomarkers (50 papers). Reno Debets is often cited by papers focused on CAR-T cell therapy research (80 papers), Immunotherapy and Immune Responses (53 papers) and Cancer Immunotherapy and Biomarkers (50 papers). Reno Debets collaborates with scholars based in Netherlands, United Kingdom and Germany. Reno Debets's co-authors include C. B. H. W. Lamers, Stefan Sleijfer, Jan W. Gratama, Ralph A. Willemsen, Egbert Oosterwijk, Hinrich Abken, Coen Govers, Errol P. Prens, Arnold G. Vulto and C.A.M. van der Velden-de Groot and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Reno Debets

151 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

2013 561 citations Stefan Sleijfer, Reno Debets et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Reno Debets	4.1k	3.1k	1.7k	1.4k	782	161	6.2k
Chrystal M. Paulos	5.4k 1.3×	5.5k 1.8×	2.3k 1.3×	1.1k 0.7×	795 1.0×	132	9.2k
John E. Janik	3.4k 0.8×	3.0k 1.0×	1.8k 1.0×	1.0k 0.7×	369 0.5×	142	7.5k
Pawel Muranski	4.8k 1.2×	5.5k 1.7×	1.7k 1.0×	989 0.7×	444 0.6×	81	7.8k
Willem W. Overwijk	4.9k 1.2×	7.1k 2.3×	2.7k 1.6×	931 0.7×	496 0.6×	112	9.6k
Radek Špíšek	3.3k 0.8×	4.8k 1.5×	1.9k 1.1×	431 0.3×	829 1.1×	134	7.6k
Michael I. Nishimura	3.2k 0.8×	4.6k 1.5×	1.8k 1.1×	885 0.6×	245 0.3×	135	6.5k
Christoph Huber	3.5k 0.9×	5.0k 1.6×	3.3k 1.9×	904 0.6×	315 0.4×	155	8.6k
Kristen E. Pauken	4.5k 1.1×	5.4k 1.7×	1.4k 0.8×	565 0.4×	292 0.4×	39	8.0k
Hideaki Tahara	3.5k 0.8×	5.1k 1.6×	3.6k 2.1×	1.9k 1.3×	211 0.3×	172	9.0k
Mads Hald Andersen	3.4k 0.8×	4.7k 1.5×	2.6k 1.5×	433 0.3×	201 0.3×	206	7.1k

Countries citing papers authored by Reno Debets

Since Specialization

Citations

This map shows the geographic impact of Reno Debets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reno Debets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reno Debets more than expected).

Fields of papers citing papers by Reno Debets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reno Debets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reno Debets. The network helps show where Reno Debets may publish in the future.

Co-authorship network of co-authors of Reno Debets

This figure shows the co-authorship network connecting the top 25 collaborators of Reno Debets. A scholar is included among the top collaborators of Reno Debets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reno Debets. Reno Debets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

French, Pim J., et al.. (2025). T cell immunity in glioma and potential implications for immunotherapy: A systematic review. Neuro-Oncology. 28(2). 334–352.

Belcaid, Zineb, Rutger K. Balvers, Thierry van den Bosch, et al.. (2025). Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological Studies. Cancers. 17(4). 603–603.

Amin, Mohamadreza, Vito D’Agostino, Mojtaba Falahati, et al.. (2024). Lipid-based nanosystems: the next generation of cancer immune therapy. Journal of Hematology & Oncology. 17(1). 53–53. 31 indexed citations

Elbers, Joris B.W., Reno Debets, Stijn Keereweer, et al.. (2023). HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial. BMC Cancer. 23(1). 541–541. 4 indexed citations

Koning, Willem de, et al.. (2023). Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients. Cancers. 15(17). 4349–4349. 1 indexed citations

Debets, Reno, et al.. (2022). Detection of Low-Frequency Epitope-Specific T Cells in Blood of Healthy Individuals according to an Optimized In Vitro Amplification System. The Journal of Immunology. 209(11). 2239–2247.

Wijers, Rebecca, Senada Koljenović, Stefan Sleijfer, et al.. (2022). Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients. Cancers. 14(17). 4298–4298. 6 indexed citations

Klaver, Yarne, et al.. (2022). Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program. Cancers. 14(6). 1377–1377. 10 indexed citations

Smid, Marcel, Ronald van Marion, Dora Hammerl, et al.. (2021). Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells. Biology. 10(8). 768–768.

10.

Hoorens, Mark W. H., et al.. (2021). Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy. Cancers. 13(5). 1100–1100. 46 indexed citations

11.

Hammerl, Dora, John W.M. Martens, Mieke Timmermans, et al.. (2021). Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer. Nature Communications. 12(1). 5668–5668. 135 indexed citations

12.

Mutsaers, Pim, Hayri E. Balcıoğlu, Rowan Kuiper, et al.. (2021). V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma. Cancers. 13(9). 2219–2219. 12 indexed citations

13.

With, Mirjam de, Daan P. Hurkmans, Esther Oomen‐de Hoop, et al.. (2021). Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy. Cancers. 13(6). 1370–1370. 9 indexed citations

14.

Zalba, Sara, et al.. (2020). Quantification of Pharmacokinetic Profiles of PD-1/PD-L1 Antibodies by Validated ELISAs. Pharmaceutics. 12(6). 595–595. 9 indexed citations

15.

Hammerl, Dora, Maarten P.G. Massink, Marcel Smid, et al.. (2019). Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes. Clinical Cancer Research. 26(2). 505–517. 37 indexed citations

16.

Basak, Edwin A., Stijn L.W. Koolen, Daan P. Hurkmans, et al.. (2019). Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer. European Journal of Cancer. 109. 12–20. 54 indexed citations

17.

Zalba, Sara, et al.. (2019). <p>Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response</p>. International Journal of Nanomedicine. Volume 14. 2069–2089. 31 indexed citations

18.

Verhoef, Esther I., Marcel Smid, René Böttcher, et al.. (2018). Epithelial–Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression. Cancer Research. 78(16). 4671–4679. 43 indexed citations

19.

Manzo, Teresa, Veronica Basso, Rodrigo Hess Michelini, et al.. (2016). T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors. Cancer Research. 77(3). 658–671. 21 indexed citations

20.

Bobisse, Sara, Maria Rondina, Anna Merlo, et al.. (2009). Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors. Cancer Research. 69(24). 9385–9394. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact